In vitro enhanced cellular iron uptake was observed with no effect on prostate cancer cell viability, whereas, specific binding to PSMA-J591 MNP was found when studied in vivo in orthotopic tumor-bearing NOD/SCID mice for 2 h and 24 h via an intravenous injection. This evidence concerns the gene FOLH1 and Familial prostate cancer.